HEAD AND NECK (HNSCC)
Clinical trials for HEAD AND NECK (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK (HNSCC) trials appear
Sign up with your email to follow new studies for HEAD AND NECK (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to fight tough cancers
Disease control Recruiting nowThis early-stage study is testing a new oral drug called CP-383 in people with advanced solid tumors that have spread or returned. The main goals are to find a safe dose and see if the drug can slow or stop cancer growth. It is for patients who have run out of standard treatment …
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Two-Pronged cancer drug enters human testing
Disease control Recruiting nowThis early-stage study is testing a new drug called GI-108 in people with advanced or spreading solid tumors, including lung, head and neck, pancreatic, and kidney cancers. The main goals are to find a safe dose and see if the drug shows any signs of helping to shrink tumors. The…
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC